Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapies for diseases of the eye, primarily Glaucoma. Its main product candidate is Trabodenoson monotherapy. The company’s product pipeline includes Trabodenoson monotherapy in an eye drop formulation and also trabodenoson plus latanoprost in an eye drop formulation.